Models for pulmonary hypertension

Drug Discovery Today: Disease Models

Volumn 1, Issue 3, 2004, Pages 289-296

  Marsboom, Glenn R ^a   Janssens, Stefan P ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANGIOPOIETIN 1; ANTU; BLEOMYCIN; BOSENTAN; CALCIUM BINDING PROTEIN; CALVASCULIN; ELASTASE INHIBITOR; ENDOTHELIN 1; FENFLURAMINE; GALECTIN 1; MICROSPHERE; MONOCROTALINE; NITRIC OXIDE; PROSTACYCLIN; SEMAXANIB; TENASCIN; TROPOMYOSIN; UNCLASSIFIED DRUG; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 2; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ACUTE DISEASE; BMPR2 GENE; CHRONIC DISEASE; CORONARY ARTERY BLOOD FLOW; DISEASE MODEL; EXERCISE; EXPERIMENTAL MODEL; GENE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; LUNG ARTERY PRESSURE; LUNG FIBROSIS; NONHUMAN; PATHOPHYSIOLOGY; PNEUMONIA; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REVIEW; STREPTOCOCCUS AGALACTIAE; TESTIS CANCER; THROMBOGENICITY;

EID: 23644453290     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2004.11.026     Document Type: Review

References (44)

1. Mannino, D.M. et al. (2002) Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill. Summ. 51, 1-16
2. Simonneau, G. et al. (2004) Clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 43 (12 Suppl. S), 5S-12S
3. Pietra, G.G. et al. (2004) Pathologic assessment of vasculopathies in pulmonary hypertension. J. Am. Coll. Cardiol. 43 (12 Suppl. S), 25S-32S
4. Lane, K.B. et al. (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat. Genet. 26, 81-84
5. Thomson, J.R. et al. (2000) Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J. Med. Genet. 37, 741-745
6. Goto, J. et al. (2002) Heme oxygenase-1 reduces murine monocrotaline-induced pulmonary inflammatory responses and resultant right ventricular overload. Antioxid. Redox Signal. 4, 563-568
7. Millatt, L.J. et al. (2003) Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension. Circulation 108, 1493-1498
8. Nong, Z. et al. (1996) Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling. Circulation 94, 1941-1947
9. Steudel, W. et al. (1998) Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J. Clin. Invest. 101, 2468-2477
10. Janssens, S.P. et al. (1991) Polycythemia and vascular remodeling in chronic hypoxic pulmonary hypertension in guinea pigs. J. Appl. Physiol. 71, 2218-2223
11. Meyrick, B. and Reid, L. (1980) Hypoxia-induced structural changes in the media and adventitia of the rat hilar pulmonary artery and their regression. Am. J. Pathol. 100, 151-178
12. Rondelet, B. et al. (2003) Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Circulation 107, 1329-1335
13. Weimann, J. et al. (2000) Effects of oxygen and nitric oxide inhalation in a porcine model of recurrent microembolism. Acta Anaesthesiol. Scand. 44, 1109-1115
14. Zagorski, J. et al. (2003) Chemokines accumulate in the lungs of rats with severe pulmonary embolism induced by polystyrene microspheres. J. Immunol. 171, 5529-5536
15. Campbell, A.I. et al. (2001) Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation 104, 2242-2248
16. Cowan, K.N. et al. (2000) Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat. Med. 6, 698-702
17. Jones, PL. et al. (1997) Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J. Cell Biol. 139, 279-293
18. Hill, N.S. et al. ( 1984) Repeated lung injury due to alpha-naphthylthiourea causes right ventricular hypertrophy in rats. J. Appl. Physiol. 56, 388-396
19. Azoulay, E. et al. (2003) Granulocyte colony-stimulating factor enhances alpha-naphthylthiourea-induced pulmonary hypertension. J. Appl. Physiol. 94, 2027-2033
20. Ortiz, L.A. et al. (2002) Enalapril protects mice from pulmonary hypertension by inhibiting TNF-mediated activation of NF-kappaB and AP-1. Am. J. Physiol. Lung Cell Mol. Physiol. 282, L1209-L1221
21. Curtis, J. et al. (2003) Group B streptococcal phospholipid causes pulmonary hypertension. Proc. Natl. Acad. Sci. USA 100, 5087-5090
22. Navarrete, C.T. et al. (2003) The role of endothelin converting enzyme inhibition during group B streptococcus-induced pulmonary hypertension in newborn piglets. Pediatr. Res. 54, 387-392
23. Le Cras, TD. et al. (2002) Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am. J. Physiol. Lung Cell Mol. Physiol. 283, L555-L562
24. Taraseviciene-Stewart, L. et al. (2001) Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J. 15, 427-438
25. Partovian, C. et al. (2000) Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. Am. J. Respir. Cell Mol. Biol. 23, 762-771
26. Du, L. et al. (2003) Signaling molecules in nonfamilial pulmonary hypertension. N. Engl. J. Med. 348, 500-509
27. Chu, D. et al. (2004) A new animal model for pulmonary hypertension based on the overexpression of a single gene, angiopoietin-1. Ann. Thorac. Surg. 77, 449-456 (discussion 456-447)
28. Zhao, Y.D. et al. (2003) Protective role of angiopoietin-1 in experimental pulmonary hypertension. Circ. Res. 92, 984-991
29. Abenhaim, L. et al. (1996) Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Stuuudy Group. N. Engl. J. Med. 335, 609-616
30. Eddahibi, S. et al. (2001) Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats. J. Pharmacol. Exp. Ther. 297, 148-154
31. Kentera, D. et al. (1988) Pulmonary artery pressure in rats with hereditary platelet function defect. Respiration 54, 110-114
32. Sato, K. et al. (1992) Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat. Am. Rev. Respir. Dis. 145 (4 Pt 1), 793-797
33. Le Cras, T.D. et al. (1999) Abnormal lung growth and the development of pulmonary hypertension in the Fawn-Hooded rat. Am. J. Physiol. 277 (4 Pt 1), L709-L718
34. Jakkula, M. et al. (2000) Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am. J. Physiol. Lung Cell Mol. Physiol. 279, L600-L607
35. Zamora, M.R. et al. (1996) Overexpression of endothelin-1 and enhanced growth of pulmonary artery smooth muscle cells from fawn-hooded rats. Am. J. Physiol. 270 (1 Pt 1), L101-L109
36. Peacock, A.J. et al. (1989) The relationship between rapid growth and pulmonary hemodynamics in the fast-growing broiler chicken. Am. Rev. Respir. Dis. 139, 1524-1530
37. Xiang, R.P. et al. (2004) Sodium chloride-induced acute and chronic pulmonary hypertension syndrome in broiler chickens. Poult. Sci. 83, 732-736
38. Martinez-Lemus, L.A. et al. (1999) Pulmonary artery endothelium-dependent vasodilation is impaired in a chicken model of pulmonary hypertension. Am. J. Physiol. 277 (1 Pt 2), R190-R197
39. Wideman, R.F. Jr. et al. (1995) Supplemental L-arginine attenuates pulmonary hypertension syndrome (ascites) in broilers. Poult. Sci. 74, 323-330
40. West, J. et al. (2004) Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ. Res. 94, 1109-1114
41. Greenway, S. et al. (2004) S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy. Am. J. Pathol. 164, 253-262
42. Chiche, J.D. et al. (1998) Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP. J. Biol. Chem. 273, 34263-34271
43. Budts, W. et al. (2000) Aerosol gene transfer with inducible nitric oxide synthase reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation 102, 2880-2885
44. Cool, C.D. et al. (2003) Expression of human herpesvirus 8 in primary pulmonary hypertension. N. Engl. J. Med. 349, 1113-1122